Global Pharmaceutical Excipients

Pharmaceutical Excipients Comprehensive Study by Type (Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides}, Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)}), Function (Fillers and diluents, Binders, Coatings, Flavoring agents, Disintegrates, Colorants, Others), Formulation (Oral Formulations, Topical Formulations, Others) Players and Region - Global Market Outlook to 2028

Pharmaceutical Excipients Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Pharmaceutical Excipients
Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. They help to streamline the manufacture of the drug product and ultimately facilitate the physiological absorption of the drug. They also help to facilitate drug absorption, solubility or other pharmacokinetic considerations.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Pharmaceutical Excipients market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

DuPont de Nemours, Inc. (United States), Roquette Feres (France), Ashland Global Holdings, Inc. (United States), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (United Kingdom), Archer Daniels Midland Company (United States), Lubrizol Corporation (United States), Croda International (United Kingdom) and Kerry Group plc (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are WACKER Chemie AG (Germany), Colorcon, Inc. (United States), DFE Pharma (Germany) and Air Liquide (France).

Segmentation Overview
AMA Research has segmented the market of Global Pharmaceutical Excipients market by Type (Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides} and Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)}) and Region.



On the basis of geography, the market of Pharmaceutical Excipients has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Function, the sub-segment i.e. Fillers and diluents will boost the Pharmaceutical Excipients market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Formulation, the sub-segment i.e. Oral Formulations will boost the Pharmaceutical Excipients market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
High Demand for Superior Quality Excipients

Market Growth Drivers:
Increasing Demand for Oral Solid Pharmaceutical Drugs and Increasing Incidence of Lifestyle Diseases

Challenges:
Stringent Government Rules and Regulations

Restraints:
Higher Production Cost

Opportunities:
Growing Pharmaceutical Industry Worldwide and Increasing Demand from Emerging Economies

Market Leaders and their expansionary development strategies
Recently, Roquette, a global leader in innovative plant-based ingredients, completed the acquisition of Itracel and reinforces its ambition of being a leader in pharmaceutical excipients. Itacel is a leading player in the pharmaceutical excipients market in Brazil and Latin America.



Key Target Audience
Pharmaceutical Excipients Manufacturers, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides}
  • Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)}
By Function
  • Fillers and diluents
  • Binders
  • Coatings
  • Flavoring agents
  • Disintegrates
  • Colorants
  • Others

By Formulation
  • Oral Formulations
  • Topical Formulations
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Oral Solid Pharmaceutical Drugs
      • 3.2.2. Increasing Incidence of Lifestyle Diseases
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. High Demand for Superior Quality Excipients
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Excipients, by Type, Function, Formulation and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Excipients (Value)
      • 5.2.1. Global Pharmaceutical Excipients by: Type (Value)
        • 5.2.1.1. Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides}
        • 5.2.1.2. Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)}
      • 5.2.2. Global Pharmaceutical Excipients by: Function (Value)
        • 5.2.2.1. Fillers and diluents
        • 5.2.2.2. Binders
        • 5.2.2.3. Coatings
        • 5.2.2.4. Flavoring agents
        • 5.2.2.5. Disintegrates
        • 5.2.2.6. Colorants
        • 5.2.2.7. Others
      • 5.2.3. Global Pharmaceutical Excipients by: Formulation (Value)
        • 5.2.3.1. Oral Formulations
        • 5.2.3.2. Topical Formulations
        • 5.2.3.3. Others
      • 5.2.4. Global Pharmaceutical Excipients Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Pharmaceutical Excipients: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DuPont de Nemours, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Roquette Feres (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ashland Global Holdings, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BASF SE (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Evonik Industries AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Associated British Foods plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Archer Daniels Midland Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lubrizol Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Croda International (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kerry Group plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmaceutical Excipients Sale, by Type, Function, Formulation and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Excipients (Value)
      • 7.2.1. Global Pharmaceutical Excipients by: Type (Value)
        • 7.2.1.1. Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides}
        • 7.2.1.2. Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)}
      • 7.2.2. Global Pharmaceutical Excipients by: Function (Value)
        • 7.2.2.1. Fillers and diluents
        • 7.2.2.2. Binders
        • 7.2.2.3. Coatings
        • 7.2.2.4. Flavoring agents
        • 7.2.2.5. Disintegrates
        • 7.2.2.6. Colorants
        • 7.2.2.7. Others
      • 7.2.3. Global Pharmaceutical Excipients by: Formulation (Value)
        • 7.2.3.1. Oral Formulations
        • 7.2.3.2. Topical Formulations
        • 7.2.3.3. Others
      • 7.2.4. Global Pharmaceutical Excipients Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Excipients: by Type(USD Million)
  • Table 2. Pharmaceutical Excipients Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides} , by Region USD Million (2017-2022)
  • Table 3. Pharmaceutical Excipients Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)} , by Region USD Million (2017-2022)
  • Table 4. Pharmaceutical Excipients: by Function(USD Million)
  • Table 5. Pharmaceutical Excipients Fillers and diluents , by Region USD Million (2017-2022)
  • Table 6. Pharmaceutical Excipients Binders , by Region USD Million (2017-2022)
  • Table 7. Pharmaceutical Excipients Coatings , by Region USD Million (2017-2022)
  • Table 8. Pharmaceutical Excipients Flavoring agents , by Region USD Million (2017-2022)
  • Table 9. Pharmaceutical Excipients Disintegrates , by Region USD Million (2017-2022)
  • Table 10. Pharmaceutical Excipients Colorants , by Region USD Million (2017-2022)
  • Table 11. Pharmaceutical Excipients Others , by Region USD Million (2017-2022)
  • Table 12. Pharmaceutical Excipients: by Formulation(USD Million)
  • Table 13. Pharmaceutical Excipients Oral Formulations , by Region USD Million (2017-2022)
  • Table 14. Pharmaceutical Excipients Topical Formulations , by Region USD Million (2017-2022)
  • Table 15. Pharmaceutical Excipients Others , by Region USD Million (2017-2022)
  • Table 16. South America Pharmaceutical Excipients, by Country USD Million (2017-2022)
  • Table 17. South America Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 18. South America Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 19. South America Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 20. Brazil Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 21. Brazil Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 22. Brazil Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 23. Argentina Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 24. Argentina Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 25. Argentina Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 26. Rest of South America Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 28. Rest of South America Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 29. Asia Pacific Pharmaceutical Excipients, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 32. Asia Pacific Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 33. China Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 34. China Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 35. China Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 36. Japan Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 37. Japan Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 38. Japan Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 39. India Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 40. India Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 41. India Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 42. South Korea Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 43. South Korea Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 44. South Korea Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 45. Taiwan Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 46. Taiwan Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 47. Taiwan Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 48. Australia Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 49. Australia Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 50. Australia Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 54. Europe Pharmaceutical Excipients, by Country USD Million (2017-2022)
  • Table 55. Europe Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 56. Europe Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 57. Europe Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 58. Germany Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 59. Germany Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 60. Germany Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 61. France Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 62. France Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 63. France Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 64. Italy Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 65. Italy Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 66. Italy Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 67. United Kingdom Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 68. United Kingdom Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 69. United Kingdom Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 70. Netherlands Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 71. Netherlands Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 72. Netherlands Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 73. Rest of Europe Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 74. Rest of Europe Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 75. Rest of Europe Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 76. MEA Pharmaceutical Excipients, by Country USD Million (2017-2022)
  • Table 77. MEA Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 78. MEA Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 79. MEA Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 80. Middle East Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 81. Middle East Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 82. Middle East Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 83. Africa Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 84. Africa Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 85. Africa Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 86. North America Pharmaceutical Excipients, by Country USD Million (2017-2022)
  • Table 87. North America Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 88. North America Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 89. North America Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 90. United States Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 91. United States Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 92. United States Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 93. Canada Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 94. Canada Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 95. Canada Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 96. Mexico Pharmaceutical Excipients, by Type USD Million (2017-2022)
  • Table 97. Mexico Pharmaceutical Excipients, by Function USD Million (2017-2022)
  • Table 98. Mexico Pharmaceutical Excipients, by Formulation USD Million (2017-2022)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Pharmaceutical Excipients: by Type(USD Million)
  • Table 110. Pharmaceutical Excipients Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides} , by Region USD Million (2023-2028)
  • Table 111. Pharmaceutical Excipients Organic Chemicals {Carbohydrates (Sugar, Starch and Cellulose) and Petrochemicals (Glycols, Povidones polymers, Mineral Hydrocarbons, Oleochemicals and Gelatin)} , by Region USD Million (2023-2028)
  • Table 112. Pharmaceutical Excipients: by Function(USD Million)
  • Table 113. Pharmaceutical Excipients Fillers and diluents , by Region USD Million (2023-2028)
  • Table 114. Pharmaceutical Excipients Binders , by Region USD Million (2023-2028)
  • Table 115. Pharmaceutical Excipients Coatings , by Region USD Million (2023-2028)
  • Table 116. Pharmaceutical Excipients Flavoring agents , by Region USD Million (2023-2028)
  • Table 117. Pharmaceutical Excipients Disintegrates , by Region USD Million (2023-2028)
  • Table 118. Pharmaceutical Excipients Colorants , by Region USD Million (2023-2028)
  • Table 119. Pharmaceutical Excipients Others , by Region USD Million (2023-2028)
  • Table 120. Pharmaceutical Excipients: by Formulation(USD Million)
  • Table 121. Pharmaceutical Excipients Oral Formulations , by Region USD Million (2023-2028)
  • Table 122. Pharmaceutical Excipients Topical Formulations , by Region USD Million (2023-2028)
  • Table 123. Pharmaceutical Excipients Others , by Region USD Million (2023-2028)
  • Table 124. South America Pharmaceutical Excipients, by Country USD Million (2023-2028)
  • Table 125. South America Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 126. South America Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 127. South America Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 128. Brazil Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 129. Brazil Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 130. Brazil Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 131. Argentina Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 132. Argentina Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 133. Argentina Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 134. Rest of South America Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 136. Rest of South America Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 137. Asia Pacific Pharmaceutical Excipients, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 140. Asia Pacific Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 141. China Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 142. China Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 143. China Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 144. Japan Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 145. Japan Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 146. Japan Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 147. India Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 148. India Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 149. India Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 150. South Korea Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 151. South Korea Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 152. South Korea Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 153. Taiwan Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 154. Taiwan Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 155. Taiwan Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 156. Australia Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 157. Australia Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 158. Australia Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 162. Europe Pharmaceutical Excipients, by Country USD Million (2023-2028)
  • Table 163. Europe Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 164. Europe Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 165. Europe Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 166. Germany Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 167. Germany Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 168. Germany Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 169. France Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 170. France Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 171. France Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 172. Italy Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 173. Italy Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 174. Italy Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 175. United Kingdom Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 177. United Kingdom Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 178. Netherlands Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 179. Netherlands Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 180. Netherlands Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 181. Rest of Europe Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 183. Rest of Europe Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 184. MEA Pharmaceutical Excipients, by Country USD Million (2023-2028)
  • Table 185. MEA Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 186. MEA Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 187. MEA Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 188. Middle East Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 189. Middle East Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 190. Middle East Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 191. Africa Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 192. Africa Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 193. Africa Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 194. North America Pharmaceutical Excipients, by Country USD Million (2023-2028)
  • Table 195. North America Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 196. North America Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 197. North America Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 198. United States Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 199. United States Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 200. United States Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 201. Canada Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 202. Canada Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 203. Canada Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 204. Mexico Pharmaceutical Excipients, by Type USD Million (2023-2028)
  • Table 205. Mexico Pharmaceutical Excipients, by Function USD Million (2023-2028)
  • Table 206. Mexico Pharmaceutical Excipients, by Formulation USD Million (2023-2028)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Excipients: by Type USD Million (2017-2022)
  • Figure 5. Global Pharmaceutical Excipients: by Function USD Million (2017-2022)
  • Figure 6. Global Pharmaceutical Excipients: by Formulation USD Million (2017-2022)
  • Figure 7. South America Pharmaceutical Excipients Share (%), by Country
  • Figure 8. Asia Pacific Pharmaceutical Excipients Share (%), by Country
  • Figure 9. Europe Pharmaceutical Excipients Share (%), by Country
  • Figure 10. MEA Pharmaceutical Excipients Share (%), by Country
  • Figure 11. North America Pharmaceutical Excipients Share (%), by Country
  • Figure 12. Global Pharmaceutical Excipients share by Players 2022 (%)
  • Figure 13. Global Pharmaceutical Excipients share by Players (Top 3) 2022(%)
  • Figure 14. Global Pharmaceutical Excipients share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. DuPont de Nemours, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. DuPont de Nemours, Inc. (United States) Revenue: by Geography 2022
  • Figure 18. Roquette Feres (France) Revenue, Net Income and Gross profit
  • Figure 19. Roquette Feres (France) Revenue: by Geography 2022
  • Figure 20. Ashland Global Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Ashland Global Holdings, Inc. (United States) Revenue: by Geography 2022
  • Figure 22. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 23. BASF SE (Germany) Revenue: by Geography 2022
  • Figure 24. Evonik Industries AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Evonik Industries AG (Germany) Revenue: by Geography 2022
  • Figure 26. Associated British Foods plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Associated British Foods plc (United Kingdom) Revenue: by Geography 2022
  • Figure 28. Archer Daniels Midland Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Archer Daniels Midland Company (United States) Revenue: by Geography 2022
  • Figure 30. Lubrizol Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Lubrizol Corporation (United States) Revenue: by Geography 2022
  • Figure 32. Croda International (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Croda International (United Kingdom) Revenue: by Geography 2022
  • Figure 34. Kerry Group plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 35. Kerry Group plc (Ireland) Revenue: by Geography 2022
  • Figure 36. Global Pharmaceutical Excipients: by Type USD Million (2023-2028)
  • Figure 37. Global Pharmaceutical Excipients: by Function USD Million (2023-2028)
  • Figure 38. Global Pharmaceutical Excipients: by Formulation USD Million (2023-2028)
  • Figure 39. South America Pharmaceutical Excipients Share (%), by Country
  • Figure 40. Asia Pacific Pharmaceutical Excipients Share (%), by Country
  • Figure 41. Europe Pharmaceutical Excipients Share (%), by Country
  • Figure 42. MEA Pharmaceutical Excipients Share (%), by Country
  • Figure 43. North America Pharmaceutical Excipients Share (%), by Country
List of companies from research coverage that are profiled in the study
  • DuPont de Nemours, Inc. (United States)
  • Roquette Feres (France)
  • Ashland Global Holdings, Inc. (United States)
  • BASF SE (Germany)
  • Evonik Industries AG (Germany)
  • Associated British Foods plc (United Kingdom)
  • Archer Daniels Midland Company (United States)
  • Lubrizol Corporation (United States)
  • Croda International (United Kingdom)
  • Kerry Group plc (Ireland)
Additional players considered in the study are as follows:
WACKER Chemie AG (Germany) , Colorcon, Inc. (United States) , DFE Pharma (Germany) , Air Liquide (France)
Select User Access Type

Key Highlights of Report


Nov 2023 203 Pages 76 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical Excipients Quantitative research analysis
Global Pharmaceutical Excipients Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as DuPont de Nemours, Inc. (United States), Roquette Feres (France), Ashland Global Holdings, Inc. (United States), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (United Kingdom), Archer Daniels Midland Company (United States), Lubrizol Corporation (United States), Croda International (United Kingdom) and Kerry Group plc (Ireland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"High Demand for Superior Quality Excipients" is seen as one of major influencing trends for Pharmaceutical Excipients Market during projected period 2022-2028.
The Pharmaceutical Excipients market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Pharmaceutical Excipients Report?

Have a Query? Click Here

Other Related Reports

Hyperimmune Globulins Comprehensive Study by Type (Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Others), Application (Government Institutions, Private Sector, Others)...
$ 3650
Immunoglobulin Products Comprehensive Study by Type (IgA, IgG, IgM, IgD, IgE), Application (Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Hypogammaglobulinemia, Immunode...
$ 3750
Hyperphosphatemia Drugs Comprehensive Study by Type (Aluminum Phosphate Binder, Iron Phosphate Binder, Magnesium Phosphate Binder, Calcium Phosphate Binder), Application (Hospitals, Clinics, Others),...
$ 3650
Cancer CDK Inhibitors Comprehensive Study by Type (Ibrance (palbociclib), Kisqali (ribociclib), Verzenio (abemaciclib)), Application (Hospitals, Clinics, Other), Distribution Channel (Hospital Pharma...
$ 3350
Human Chorionic Gonadotropin Comprehensive Study by Technology (Natural Source Extraction, Recombinant Technology), End User (Fertility Clinics, Research Institutions, Others), Therapeutic Area (Fema...
$ 3450
Hib Vaccine Comprehensive Study by Type (Type 1-HIB Vaccine, Type 2- DTaP-IPV), Form (Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB, Lyophilized Combination HIB), Age Grou...
$ 3750